Articles of Interest

STICKY: Global Coronavirus COVID-19 Clinical Trial Tracker


Molnupiravir: FDA Authorizes Additional Oral Antiviral for Treatment of COVID-19 in Certain Adults


Paxlovid: Coronavirus (COVID-19) Update: FDA Authorizes First Oral Antiviral for Treatment of COVID-

           Assessment of Evidence for COVID-19-Related Treatments


ANTICOAG: Full-dose blood thinners decreased need for life support and improved outcome in hospitali


Monclonal Ab Tx: Regeron FDA EUA Authorization in high risk outpatients


Monclonal Ab Tx: Regeneron: Halts Enrollment of Critically Ill Patients in COVID-19 Antibody Trial


Monclonal Ab: Monoclonal antibodies cut risk of dying from COVID-19—but only in some patients


Monclonal Ab Tx: Eli-Lily Ab therapy gets FDA emergency authorization


Baricitinib : FDA Authorizes Baricitinib/Remdesivir Combo for COVID-19


STEROIDS: Coronavirus: Dexamethasone proves first life-saving drug


STEROIDS: Low-cost dexamethasone reduces death by up to one third in hospitalised patients with seve


STEROIDS: Dexmethasone Recovery Trial Data Summary Article


STEROIDS: Dexamethasone in Hospitalized Patients with Covid-19 — NEJM


STEROIDS: Corticosteroids Should Be First Line of Treatment For Severe COVID-19, WHO Says


STEROIDS: Association Between Administration of Systemic Corticosteroids and Mortality Among Critica


Baricitinib : FDA Authorizes Baricitinib/Remdesivir Combo for COVID-19


Remdesivir: Early Remdesivir to Prevent Progression to Severe Covid-19 in Outpatients (PINETREE STUD


Remdesivir: Compassionate Use of Remdesivir for Patients with Severe Covid-19


Remdesivir: effective against a key enzyme of coronavirus that causes COVID-19?


Remdesivir: Early peek at data on Gilead coronavirus drug suggests patients are responding to treatm


Remdesivir: New data on Gilead’s remdesivir, released by accident, show no benefit for corona


Remdesivir: a randomised, double-blind, placebo-controlled, multicentre trial (China)


Remdesivir: ACTT Trial - NIH clinical trial shows Remdesivir accelerates recovery from advanced COVI


Remdesivir: Remdesivir Fails to Prevent Covid-19 Deaths in Huge Trial (WHO/NYTimes)


Tocilizumab NEJM Quick Take: in Covid-19 Pneumonia


Tocilizumab: 2 Arthritis Drugs Reduce Deaths in Very Ill Covid Patients, Study Finds


Tocilizumab: Arthritis Drug Tocilizumab Proves Ineffective In Treating Covid-19, Two Randomized Stud


Tocilizumab: Studies find mixed results for tocilizumab to treat COVID-19


Tocilizumab: Tocilizumab in Hospitalized Patients with Severe Covid-19 Pneumonia


Tocilizumab: Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, co